Literature DB >> 17072783

[Percutaneously implantable aortic valve: the JenaValve concept evolution].

Hans R Figulla1, Markus Ferrari.   

Abstract

Due to the increasing incidence of severe aortic stenosis in old and multimorbid patients, the percutaneous implantation of aortic valve-carrying stents has become an alternative to the surgical replacement of aortic valves. Starting in 1995, the authors developed a self-expanding stent which transferred the necessary forces for anchoring up to the aorta ascendens-a conception taken over from CoreValve. The further improvement of this idea over the past 11 years has led to a self-expanding, relatively short stent-valve system that is reliably positioned in the cusps of the old aortic valve and holds the old valve like a paper clip, thus transferring the holding forces physiologically. As compared to conventional systems, the sophisticated insertion catheter requires further chronic animal tests so as to represent a true alternative to the conventional surgical procedure.

Entities:  

Mesh:

Year:  2006        PMID: 17072783     DOI: 10.1007/s00059-006-2904-9

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  7 in total

Review 1.  Current developments in transcatheter aortic valve implantation techniques.

Authors:  M Thielmann; P Kahlert; T Konorza; R Erbel; H Jakob; D Wendt
Journal:  Herz       Date:  2011-12       Impact factor: 1.443

2.  [Transcatheter aortic-valve implantation for aortic stenosis. An established procedure?].

Authors:  H R Figulla; M Ferrari
Journal:  Herz       Date:  2011-03       Impact factor: 1.443

3.  Impact of rapid ventricular pacing during TAVI on microvascular tissue perfusion.

Authors:  Anna Selle; Hans R Figulla; Markus Ferrari; Wilma Rademacher; Bjoern Goebel; Ali Hamadanchi; Marcus Franz; Andrea Schlueter; Thomas Lehmann; Alexander Lauten
Journal:  Clin Res Cardiol       Date:  2014-06-05       Impact factor: 5.460

4.  Vascular access site complications after percutaneous transfemoral aortic valve implantation.

Authors:  Philipp Kahlert; Fadi Al-Rashid; Marcel Weber; Daniel Wendt; Torsten Heine; Eva Kottenberg; Matthias Thielmann; Hilmar Kühl; Jürgen Peters; Heinz G Jakob; Stefan Sack; Raimund Erbel; Holger Eggebrecht
Journal:  Herz       Date:  2009-08       Impact factor: 1.443

Review 5.  [Surgery or medical therapy for secondary mitral regurgitation?].

Authors:  Arnd Schaefer
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

6.  Urochordates carry multiple genes for goose-type lysozyme and no genes for chicken- or invertebrate-type lysozymes.

Authors:  I W Nilsen; B Myrnes; R B Edvardsen; D Chourrout
Journal:  Cell Mol Life Sci       Date:  2003-10       Impact factor: 9.261

7.  Transapical Implantation of a 2nd-Generation JenaValve Device in Patient with Extremely High Surgical Risk.

Authors:  Juan Mieres; Marcelo Menéndez; Carlos Fernández-Pereira; Miguel Rubio; Alfredo E Rodríguez
Journal:  Case Rep Cardiol       Date:  2015-08-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.